123 related articles for article (PubMed ID: 28772167)
41. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
Guenther MK; Graab U; Fulda S
Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
[TBL] [Abstract][Full Text] [Related]
42. DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth.
Deng R; Yang F; Chang SH; Tang J; Qin J; Feng GK; Ding K; Zhu XF
Mol Pharmacol; 2012 Aug; 82(2):189-98. PubMed ID: 22553359
[TBL] [Abstract][Full Text] [Related]
43. Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1-7) action on these pathways in cultured human myotubes.
Montori-Grau M; Tarrats N; Osorio-Conles O; Orozco A; Serrano-Marco L; Vázquez-Carrera M; Gómez-Foix AM
Cell Signal; 2013 May; 25(5):1318-27. PubMed ID: 23453973
[TBL] [Abstract][Full Text] [Related]
44. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors.
Takeuchi H; Kondo Y; Fujiwara K; Kanzawa T; Aoki H; Mills GB; Kondo S
Cancer Res; 2005 Apr; 65(8):3336-46. PubMed ID: 15833867
[TBL] [Abstract][Full Text] [Related]
45. Monocytes prevent apoptosis of iPSCs and promote differentiation of kidney organoids.
Pecksen E; Tkachuk S; Schröder C; Vives Enrich M; Neog A; Johnson CP; Lachmann N; Haller H; Kiyan Y
Stem Cell Res Ther; 2024 May; 15(1):132. PubMed ID: 38702808
[TBL] [Abstract][Full Text] [Related]
46. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ
Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631
[TBL] [Abstract][Full Text] [Related]
47. A Regulatory Network Involving β-Catenin, e-Cadherin, PI3k/Akt, and Slug Balances Self-Renewal and Differentiation of Human Pluripotent Stem Cells In Response to Wnt Signaling.
Huang TS; Li L; Moalim-Nour L; Jia D; Bai J; Yao Z; Bennett SA; Figeys D; Wang L
Stem Cells; 2015 May; 33(5):1419-33. PubMed ID: 25538040
[TBL] [Abstract][Full Text] [Related]
48. Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin.
Yu K; Toral-Barza L; Shi C; Zhang WG; Lucas J; Shor B; Kim J; Verheijen J; Curran K; Malwitz DJ; Cole DC; Ellingboe J; Ayral-Kaloustian S; Mansour TS; Gibbons JJ; Abraham RT; Nowak P; Zask A
Cancer Res; 2009 Aug; 69(15):6232-40. PubMed ID: 19584280
[TBL] [Abstract][Full Text] [Related]
49. Protein kinase C-beta inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-hodgkin lymphoma cells.
Saba NS; Levy LS
J Investig Med; 2012 Jan; 60(1):29-38. PubMed ID: 21997316
[TBL] [Abstract][Full Text] [Related]
50. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
51. Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cells.
Biver E; Thouverey C; Magne D; Caverzasio J
Mol Cell Endocrinol; 2014 Jan; 382(1):120-130. PubMed ID: 24060635
[TBL] [Abstract][Full Text] [Related]
52. Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3.
Zhou Y; Uddin S; Zimmerman T; Kang JA; Ulaszek J; Wickrema A
Leuk Lymphoma; 2008 Oct; 49(10):1945-53. PubMed ID: 18728964
[TBL] [Abstract][Full Text] [Related]
53. A modified EpiSC culture condition containing a GSK3 inhibitor can support germline-competent pluripotency in mice.
Tsukiyama T; Ohinata Y
PLoS One; 2014; 9(4):e95329. PubMed ID: 24736627
[TBL] [Abstract][Full Text] [Related]
54. Controlled Release of Small Molecules for Cardiac Differentiation of Pluripotent Stem Cells.
Tsao CJ; Taraballi F; Pandolfi L; Velasquez-Mao AJ; Ruano R; Tasciotti E; Jacot JG
Tissue Eng Part A; 2018 Dec; 24(23-24):1798-1807. PubMed ID: 30129882
[TBL] [Abstract][Full Text] [Related]
55. The Tissue-Reconstructing Ability of Colon CSCs Is Enhanced by FK506 and Suppressed by GSK3 Inhibition.
Ishida R; Koyanagi-Aoi M; Oshima N; Kakeji Y; Aoi T
Mol Cancer Res; 2017 Oct; 15(10):1455-1466. PubMed ID: 28710230
[TBL] [Abstract][Full Text] [Related]
56. Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors.
Wadhwa P; Jain P; Jadhav HR
Curr Top Med Chem; 2020; 20(17):1522-1534. PubMed ID: 32416693
[TBL] [Abstract][Full Text] [Related]
57. Thiol antioxidants in combination with vitamin B12 induce apoptotic death of human lymphocytic leukemia cells by destabilization of lysosomes with the involvement of iron ions.
Solovyeva ME; Faskhutdinova AA; Solovyev VV; Akatov VS
Bull Exp Biol Med; 2013 Feb; 154(4):449-52. PubMed ID: 23486578
[TBL] [Abstract][Full Text] [Related]
58. Activation of Wnt/β-catenin signalling and HIF1α stabilisation alters pluripotency and differentiation/proliferation properties of human-induced pluripotent stem cells.
Wei H; Beeson GC; Ye Z; Zhang J; Yao H; Damon B; Morad M
Biol Cell; 2021 Mar; 113(3):133-145. PubMed ID: 33275284
[TBL] [Abstract][Full Text] [Related]
59. Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system.
Caberlotto L; Carboni L; Zanderigo F; Andreetta F; Andreoli M; Gentile G; Razzoli M
Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):893-903. PubMed ID: 23793101
[TBL] [Abstract][Full Text] [Related]
60. Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors.
Ramurthy S; Pfister KB; Boyce RS; Brown SP; Costales AQ; Desai MC; Fang E; Levine BH; Ng SC; Nuss JM; Ring DB; Shafer CM; Shu W; Subramanian S; Wagman AS; Wang H; Bussiere DE
Bioorg Med Chem Lett; 2020 Feb; 30(4):126930. PubMed ID: 31926786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
